1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- Benitec Biopharma Ltd
- Biotron Ltd
- Nexstim Plc
- MORE
Admedus Ltd (AHZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Critical Information Included
Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue repairs. Its flagship product, CardioCel is a regenerative tissue for cardiac repairs and reconstructions. The company also distributes infusion systems including ambulatory pumps, syringe and volumetric pumps, administration accessories, Amnicot finger cot, nasal spray (PCA) device and O’Neil urinary catheters. Admedus is developing next generation vaccines for the treatment and prevention of infectious diseases and cancers with an initial focus on Herpes Simplex Virus (HSV-2) and Human papillomavirus (HPV). Admedus is headquartered in Malaga, Western Australia, Australia.
Admedus Ltd Key Recent Developments
Dec 12, 2018: Admedus: Board of directors appointments
Dec 04, 2018: Admedus names Dr Kiran Bhirangi as Chief Medical Officer
Nov 26, 2018: Admedus technology names Matthew Mcdonnell as interim CFO
Nov 19, 2018: Admedus: restructure of Australian management team
Nov 01, 2018: Admedus appoints Steve Denaro to the board
Key Benefits
You get detailed information about the company and its operations to identify potential customers and suppliers.
Critical Information Included
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue repairs. Its flagship product, CardioCel is a regenerative tissue for cardiac repairs and reconstructions. The company also distributes infusion systems including ambulatory pumps, syringe and volumetric pumps, administration accessories, Amnicot finger cot, nasal spray (PCA) device and O’Neil urinary catheters. Admedus is developing next generation vaccines for the treatment and prevention of infectious diseases and cancers with an initial focus on Herpes Simplex Virus (HSV-2) and Human papillomavirus (HPV). Admedus is headquartered in Malaga, Western Australia, Australia.
Admedus Ltd Key Recent Developments
Dec 12, 2018: Admedus: Board of directors appointments
Dec 04, 2018: Admedus names Dr Kiran Bhirangi as Chief Medical Officer
Nov 26, 2018: Admedus technology names Matthew Mcdonnell as interim CFO
Nov 19, 2018: Admedus: restructure of Australian management team
Nov 01, 2018: Admedus appoints Steve Denaro to the board
Key Benefits
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- Benitec Biopharma Ltd
- Biotron Ltd
- Nexstim Plc
- MORE
Section 1 - About the Company
Admedus Ltd - Key Facts
Admedus Ltd - Key Employees
Admedus Ltd - Key Employee Biographies
Admedus Ltd - Major Products and Services
Admedus Ltd - History
Admedus Ltd - Company Statement
Admedus Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Admedus Ltd - Business Description
Admedus Ltd - SWOT Analysis
SWOT Analysis - Overview
Admedus Ltd - Strengths
Admedus Ltd - Weaknesses
Admedus Ltd - Opportunities
Admedus Ltd - Threats
Admedus Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Admedus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018
Admedus Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018
Admedus Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 12, 2018: Admedus: Board of directors appointments
Dec 04, 2018: Admedus names Dr Kiran Bhirangi as Chief Medical Officer
Nov 26, 2018: Admedus technology names Matthew Mcdonnell as interim CFO
Nov 19, 2018: Admedus: restructure of Australian management team
Oct 29, 2018: Admedus: Director resignation
Oct 04, 2018: Admedus announces Non-Executive Director resignation and appointment
Aug 09, 2018: Admedus: Distribution agreement renewed for infusion supply chain
Jul 31, 2018: Admedus: Quarterly report – Appendix 4C for the period to 30 June 2018
Jun 06, 2018: Admedus Announces Conclusion Of Relationship With Go Medical
May 23, 2018: Admedus Announce Appointment of Catherine Costello
Section 6 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer
List of Tables
Admedus Ltd, Key Facts
Admedus Ltd, Key Employees
Admedus Ltd, Key Employee Biographies
Admedus Ltd, Major Products and Services
Admedus Ltd, History
Admedus Ltd, Other Locations
Admedus Ltd, Subsidiaries
Admedus Ltd, Key Competitors
Admedus Ltd, Ratios based on current share price
Admedus Ltd, Annual Ratios
Admedus Ltd, Annual Ratios (Cont...1)
Admedus Ltd, Interim Ratios
Admedus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018
Admedus Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018
Admedus Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Admedus Ltd, Performance Chart (2013 - 2017)
Admedus Ltd, Ratio Charts
Admedus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018
Admedus Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018
Admedus Ltd - Key Facts
Admedus Ltd - Key Employees
Admedus Ltd - Key Employee Biographies
Admedus Ltd - Major Products and Services
Admedus Ltd - History
Admedus Ltd - Company Statement
Admedus Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Admedus Ltd - Business Description
Admedus Ltd - SWOT Analysis
SWOT Analysis - Overview
Admedus Ltd - Strengths
Admedus Ltd - Weaknesses
Admedus Ltd - Opportunities
Admedus Ltd - Threats
Admedus Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Admedus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018
Admedus Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018
Admedus Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 12, 2018: Admedus: Board of directors appointments
Dec 04, 2018: Admedus names Dr Kiran Bhirangi as Chief Medical Officer
Nov 26, 2018: Admedus technology names Matthew Mcdonnell as interim CFO
Nov 19, 2018: Admedus: restructure of Australian management team
Oct 29, 2018: Admedus: Director resignation
Oct 04, 2018: Admedus announces Non-Executive Director resignation and appointment
Aug 09, 2018: Admedus: Distribution agreement renewed for infusion supply chain
Jul 31, 2018: Admedus: Quarterly report – Appendix 4C for the period to 30 June 2018
Jun 06, 2018: Admedus Announces Conclusion Of Relationship With Go Medical
May 23, 2018: Admedus Announce Appointment of Catherine Costello
Section 6 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer
List of Tables
Admedus Ltd, Key Facts
Admedus Ltd, Key Employees
Admedus Ltd, Key Employee Biographies
Admedus Ltd, Major Products and Services
Admedus Ltd, History
Admedus Ltd, Other Locations
Admedus Ltd, Subsidiaries
Admedus Ltd, Key Competitors
Admedus Ltd, Ratios based on current share price
Admedus Ltd, Annual Ratios
Admedus Ltd, Annual Ratios (Cont...1)
Admedus Ltd, Interim Ratios
Admedus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018
Admedus Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018
Admedus Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Admedus Ltd, Performance Chart (2013 - 2017)
Admedus Ltd, Ratio Charts
Admedus Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018
Admedus Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
- Nexstim Plc
- Medtronic Australasia Pty Ltd
- Biotron Ltd
- Benitec Biopharma Ltd
Note: Product cover images may vary from those shown
